Stephen Davis - Sep 1, 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
Director
Signature
/s/ Stephen R. Davis
Stock symbol
BLCM
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 10:30 AM
Previous filing
Jun 16, 2022
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCM Common Stock Options Exercise $0 +43.4K +231.9% $0.00 62.1K Sep 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date.